Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

F-choline PET in Early Response Assessment for Castration Resistant Prostatic Cancer Treated by Abiraterone Acetate or Enzalutamide

NCT01981707 is registered in ClinicalTrials.gov with University Hospital, Grenoble as lead sponsor.

NCT NCT01981707
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01981707 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
F-choline PET in Early Response Assessment for Castration Resistant Prostatic Cancer Treated by Abiraterone Acetate or Enzalutamide
Lead sponsor
University Hospital, Grenoble
Phase
Phase 2/3
Overall status
Terminated
Start date
December 31, 2013
Completion date
March 31, 2016
Enrollment
12 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

castration-resistant prostate cancer